DOBUTAMINE
- Product NDC
- 51662-1330
- 11-digit product format
- 516621330
- Labeler code
- 51662
- Product ID
- 51662-1330_100c9203-3714-02bc-e063-6294a90afb2f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOBUTAMINE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- NDA020201
- Marketing category
- NDA
- Marketing start
- 2019-04-07
- Substance
- DOBUTAMINE HYDROCHLORIDE
- Active strength
- 200 mg/100mL
- Pharmacologic classes
- Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOBUTAMINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOBUTAMINE HYDROCHLORIDE | 200 mg/100mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0WR771DJXV |
| Rxcui | 309986 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1330-1 | DOBUTAMINE | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1330 | DOBUTAMINE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240130_85fb5ba6-3597-e09f-e053-2a91aa0aded5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1330-1 | 51662133001 | 250 mL in 1 BAG (51662-1330-1) | 250 ml | 2019-04-07 | 0000-00-00 | No | No | Current |